Table 3. Factors associated with adverse maternal and perinatal outcomes during expectant management of preeclampsia without severe feature at SPHMMC, 2018.
| Character. | Adverse maternal outcome. | COR(95%Cl) | AOR(95%Cl) | P-value | |
|---|---|---|---|---|---|
| Yes | No | ||||
| Age | |||||
| <20years | 16 | 25 | 1,63(0.75–3.48) | 1.26(0,56–2.81) | 0.2147 |
| 20–34 years | 28 | 71 | 1 | 1 | |
| >35 years | 12 | 12 | 2.54(1.02–6.32) | 1.56(1.01–2.77) | 0.030 |
| Gravidity | |||||
| Primigravida | 31 | 49 | 1.493(0.78–2.846) | 1.704(0.84–3.45) | 0.2260 |
| Multi gravida | 25 | 59 | 1 | 1 | |
| Gestational age | |||||
| 28–34 weeks | 19 | 14 | 4.99(2.24–11.12) | 5.22(2.01–13.6) | 0.0001 |
| 34–36 weeks | 28 | 103 | 1 | 1 | |
| Character. | Adverse perinatal outcome | ||||
| Yes | No | ||||
| Age | |||||
| <20years | 24 | 21 | 2.22(0.92–4.54) | 1.41(0.66–3.03) | 0.0285 |
| 20–34 years | 35 | 68 | 1 | 1 | |
| >35 years | 13 | 15 | 1.68(0.72–3.93) | 1.12(0.68–1.74) | 0.2281 |
| Gravidity | |||||
| Primigravida | 40 | 52 | 1.25(0.65–2.3) | 1.24(0.63–2.35) | 0.4684 |
| Multigravida | 32 | 52 | 1 | 1 | |
| Gestational age | |||||
| 28–33 weeks + 6 days. | 33 | 8 | 10.15(4.31–23.87) | 25.9(5.75–115.6) | <0.0001 |
| 34–36 weeks | 39 | 96 | 1 | 1 | |